Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Examining the Effects of Estradiol on Neural and Molecular Response to Rewards in Perimenopausal-Onset Anhedonia and Psychosis

NCT05282277 is registered in ClinicalTrials.gov with University of North Carolina, Chapel Hill as lead sponsor.

NCT NCT05282277
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05282277 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Examining the Effects of Estradiol on Neural and Molecular Response to Rewards in Perimenopausal-Onset Anhedonia and Psychosis
Lead sponsor
University of North Carolina, Chapel Hill
Phase
Phase 4
Overall status
Recruiting
Start date
April 20, 2022
Completion date
December 31, 2026
Enrollment
103 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

anhedonia, depression, psychosis